A Tale of Two Eras: The Story of Autologous Stem Cell Transplantation with and without Thiotepa for Primary Central Nervous System Lymphoma

被引：2
作者：
Hu, Bei [1 ]
机构：
[1] Levine Canc Inst Atrium Hlth, Dept Hematol Oncol & Blood Disorders, 1021 Morehead Med Dr,Suite 5300, Charlotte, NC 28204 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 05期
关键词：
HIGH-DOSE METHOTREXATE; PRIMARY CNS LYMPHOMA; WHOLE-BRAIN RADIOTHERAPY; CHEMOTHERAPY; CYCLOPHOSPHAMIDE; THERAPY; MULTICENTER; IRRADIATION; CYTARABINE; ETOPOSIDE;
D O I：
10.1016/j.bbmt.2019.03.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E141 / E142
页数：2
相关论文
共 32 条
  • [1] Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: An intent-to-treat analysis
    Abrey, LE
    Moskowitz, CH
    Mason, WP
    Crump, M
    Stewart, D
    Forsyth, P
    Paleologos, N
    Correa, DD
    Anderson, ND
    Caron, D
    Zelenetz, A
    Nimer, SD
    DeAngelis, LM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4151 - 4156
  • [2] BATCHELOR T, 2003, NATURE PROTOCOLS, V21, P1044, DOI DOI 10.1200/JCO.2003.03.036
  • [3] BORSI JD, 1987, CANCER-AM CANCER SOC, V60, P5, DOI 10.1002/1097-0142(19870701)60:1<5::AID-CNCR2820600103>3.0.CO
  • [4] 2-D
  • [5] High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma
    Cheng, G
    Forsyth, P
    Chaudhry, A
    Morris, D
    Gluck, S
    Russell, JA
    Stewart, DA
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 (08) : 679 - 685
  • [6] Autologous Stem Cell Transplantation with Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioning in Patients with CNS Involvement by Non-Hodgkin Lymphoma
    Cote, Gregory M.
    Hochberg, Ephraim P.
    Muzikansky, Alona
    Hochberg, Fred H.
    Drappatz, Jan
    McAfee, Steven L.
    Batchelor, Tracy T.
    LaCasce, Ann S.
    Fisher, David C.
    Abramson, Jeremy S.
    Armand, Philippe
    Chen, Yi-Bin
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (01) : 76 - 83
  • [7] COMBINED MODALITY THERAPY FOR PRIMARY CNS LYMPHOMA
    DEANGELIS, LM
    YAHALOM, J
    THALER, HT
    KHER, U
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (04) : 635 - 643
  • [8] Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10
    DeAngelis, LM
    Seiferheld, W
    Schold, SC
    Fisher, B
    Schultz, CJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) : 4643 - 4648
  • [9] Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 12 to 15, 2002
    Ferreri, AJM
    Abrey, LE
    Blay, JY
    Borisch, B
    Hochman, J
    Neuwelt, EA
    Yahalom, J
    Zucca, E
    Cavalli, F
    Armitage, J
    Batchelor, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (12) : 2407 - 2414
  • [10] Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients
    Ferreri, AJM
    Reni, M
    Dell'Oro, S
    Ciceri, F
    Bernardi, M
    Camba, L
    Ponzoni, M
    Terreni, MR
    Tomirotti, M
    Spina, M
    Villa, E
    [J]. ONCOLOGY, 2001, 60 (02) : 134 - 140
1234